Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for buprenorphine detoxification
NCT01262092Phase 2Completed
- Sponsor
- University of Arkansas
- Start
- Oct 2010
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in opioid withdrawal comparing Gabapentin Arm with Placebo Arm (2 arms). Primary endpoint: Illicit Opioid Use as Determine by Urine Dipsticks at week 4. Started Oct 2010; status: completed.
02
Drugs
gabapentin
03
Conditions
opioid withdrawal
Beyond the preview
Go deeper on NCT01262092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01262092.